Literature DB >> 8077258

Myelomeningocele at the sacral level. Long-term outcomes in adults.

M R Brinker1, S R Rosenfeld, E Feiwell, S P Granger, D C Mitchell, J C Rice.   

Abstract

We reviewed the long-term outcome of thirty-six patients who had a myelomeningocele at the sacral level and whose average age was twenty-nine years (range, nineteen to fifty-one years). The patients were followed at our institution for an average of ten years (range, one to thirty-three years); however, the medical records from birth on were available for all of the patients. Instead of the expected outcome that function had been maintained in this group of patients, we found a decline in the ability to walk of eleven of the thirty-five patients who had been community ambulators initially. At the time of the most recent follow-up examination, five had become household ambulators, two were non-functional ambulators, and four were non-ambulators. The one patient who initially had been a household ambulator was a non-ambulator at the time of the most recent follow-up examination. A decrease in plantar flexion was found in fourteen patients and a decrease in plantar sensation, in fifteen. Breakdown of the skin and soft-tissue infections on the plantar surface of the metatarsal heads and of the heel were seen in twenty-seven and twenty-three patients, respectively, and were related to the absence of plantar sensation. Fifteen patients had osteomyelitis involving the lower extremity. Eleven patients had had a total of fourteen amputations: five involved one toe or more, four involved one ray or more, two were Syme amputations, and three were below-the-knee amputations. By the most recent follow-up examination, thirty-three patients had had a total of 371 orthopaedic procedures. The procedures included tendinous procedures; osteotomies; soft-tissue releases, transfers, and débridements; amputations; and arthrodeses of the lower extremities or spine.

Entities:  

Mesh:

Year:  1994        PMID: 8077258     DOI: 10.2106/00004623-199409000-00003

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  8 in total

Review 1.  Obesity Prevention for Individuals with Spina Bifida.

Authors:  Michele Polfuss; Linda G Bandini; Kathleen J Sawin
Journal:  Curr Obes Rep       Date:  2017-06

2.  Cognitive and motor function in adults with spina bifida myelomeningocele: a pilot study.

Authors:  Joan Mary Jasien; Mohamad A Mikati; Michaela Kolarova; Brian Smith; Stephanie Thera; Pierre Lee
Journal:  Childs Nerv Syst       Date:  2020-11-13       Impact factor: 1.475

3.  Low level myelomeningoceles: do they need prenatal surgery?

Authors:  Pierre-Aurelien Beuriat; Isabelle Poirot; Frederic Hameury; Delphine Demede; Kieron J Sweeney; Alexandru Szathmari; Federico Di Rocco; Carmine Mottolese
Journal:  Childs Nerv Syst       Date:  2019-03-27       Impact factor: 1.475

Review 4.  Metabolic Syndrome in Children With Myelomeningocele and the Role of Physical Activity: A Narrative Review of the Literature.

Authors:  Gabrielle Gour-Provençal; Camille Costa
Journal:  Top Spinal Cord Inj Rehabil       Date:  2022-08-17

Review 5.  Surgical Management of Hip Problems in Myelomeningocele: A Review Article.

Authors:  Taghi Baghdadi; Reza Abdi; Ramin Zargar Bashi; Hossein Aslani
Journal:  Arch Bone Jt Surg       Date:  2016-06

6.  Walking activity during daily living in children with myelomeningocele.

Authors:  Pauline Yasmeh; Nicole M Mueske; Siamak Yasmeh; Deirdre D Ryan; Tishya A L Wren
Journal:  Disabil Rehabil       Date:  2016-07-06       Impact factor: 3.033

7.  Risk factors for pressure sores in adult patients with myelomeningocele--a questionnaire-based study.

Authors:  Pål-Erik Plaum; Gunnar Riemer; Kathrine Frey Frøslie
Journal:  Cerebrospinal Fluid Res       Date:  2006-12-29

8.  A snapshot of the adult spina bifida patient - high incidence of urologic procedures.

Authors:  Joceline S Liu; Alyssa Greiman; Jessica T Casey; Shubhra Mukherjee; Stephanie J Kielb
Journal:  Cent European J Urol       Date:  2016-01-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.